Mohamed El-Sherbeini

Title: Innovations of Mohamed El-Sherbeini

Introduction

Mohamed El-Sherbeini is a notable inventor based in Westfield, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of bacterial cell wall biosynthesis. With a total of 2 patents, his work has implications for both research and therapeutic applications.

Latest Patents

El-Sherbeini's latest patents include groundbreaking research on the MraY gene and enzyme of Pseudomonas aeruginosa. This patent provides polynucleotides and polypeptides of MraY, an enzyme that plays a crucial role in bacterial cell wall biosynthesis. The recombinant MraY enzyme is catalytically active in the first step of the membrane cycle of peptidoglycan biosynthesis. Additionally, the patent includes proteins encoded by the sequences, host cells expressing the recombinant enzyme, and probes and primers. Another significant patent involves DNA encoding glucan synthesis gene 1 (GLS1), which is cloned and utilized in an in vitro assay to screen for compounds that modulate 1,3-beta-D glucan synthase activity.

Career Highlights

El-Sherbeini is currently employed at Merck & Company, Inc., where he continues to advance his research in biotechnology. His work has been instrumental in developing new methodologies and understanding the mechanisms of bacterial resistance.

Collaborations

Some of his notable coworkers include Joseph A. Clemas and Barbara A. Azzolina, who have collaborated with him on various projects within the company.

Conclusion

Mohamed El-Sherbeini's contributions to biotechnology through his patents and research at Merck & Company, Inc. highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in understanding bacterial mechanisms and potential therapeutic interventions.